Professor of Otolaryngology, Harvard Medical School

Otolaryngology (ENT)

Dr. Michael J. McKenna, MD


Michael J. McKenna, MD is an expert in the field of Otolaryngology (ENT). He studied medicine at Keck School of Medicine of USC. Keck School of Medicine of USC is ranked 31/72 in Research/PrimaryCare. He has 8 awards "Vegas Seven", "America's Top Doctors", "Boston Magazine", "Desert Companion", "Boston Herald", "Fellow (FAAO-HNS)", "Super Doctor" and "Fellow (FACS)". Doctor Michael J. McKenna, MD is also a published doctor. He has 6 paper published. The most recent paper is: Sporadic Vestibular Schwannomas Associated With Good Hearing Secrete Higher Levels of Fibroblast Growth Factor 2 Than Those Associated With Poor Hearing Irrespective o... He accepts Medicare payments and is registered with Medicare.gov.



Publications


Schools


Doctors Specialties


Accepted Insurances


Awards


Education


Hospital


Drug Facts


NPI NUMBER   1093736571
NPPES Provider LastName   MCKENNA
NPPES Provider FirstName   MICHAEL
NPPES Provider ZIPCode   891485585
NPPES Provider State   NV
Specialty Description   Interventional Pain Management
Total Claim Count   558.0
Distinct Opioid Count   8.0
Opioid Claim Count   253.0
Percent Opioid Claims   45.34

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1093736571
Last Name Of The Provider MCKENNA
First Name Of The Provider MICHAEL
View All

Similar Doctors


Dr. Joel N. Lubritz, MD
This Doctor is OpenDoctor Recommended.
Dr. James E. Tinnell, MD
This Doctor is OpenDoctor Recommended.
Dr. Tsungju O-Lee, MD
This Doctor is OpenDoctor Recommended.
Dr. Fredrick Russek, MD
This Doctor is OpenDoctor Recommended.
Dr. Matthew Ng, MD
This Doctor is OpenDoctor Recommended.
Dr. Christopher G. Millson, MD
This Doctor is OpenDoctor Recommended.
Dr. John P. Anter, MD
This Doctor is OpenDoctor Recommended.
Dr. Stephen A. Gephardt, MD
This Doctor is OpenDoctor Recommended.
Dr. Charles Abdo, MD
This Doctor is OpenDoctor Recommended.


Doctor Directory | TOS | twitter | FB | Angel | blog